PulseAugur
中
实时 13:12:28
English(EN) BMS funded the AI that's supposed to tell BMS which drugs will work. $3B for a model that "calculates probability of success." every failed trial just calls it

百时美施贵宝投资30亿美元用于AI药物成功预测

作者 PulseAugur 编辑部 · [1 个来源] ·

据报道，百时美施贵宝（BMS）已投资30亿美元用于一个旨在预测新药成功率的人工智能模型。该AI旨在计算候选药物的成功概率，从而可能简化药物发现和开发流程。然而，该系统因将失败的试验仅仅标记为异常值而受到批评，引发了对其准确性和可靠性的质疑。 AI

影响 这项投资标志着制药巨头在研发领域大力推动AI应用，有望加速药物开发周期并减少试验失败。

排序理由 一家主要制药公司在药物发现领域对AI进行的大量投资。 [lever_c_demoted from significant: ic=1 ai=0.7]

在 Mastodon — mastodon.social 阅读 →

AI 生成摘要 · Google Gemini · 来自 1 个来源。 我们如何撰写摘要 →

百时美施贵宝投资30亿美元用于AI药物成功预测

本文如何被排名

Signal score
9 / 100
Composite score across the factors below. Higher = stronger signal that this story matters right now.
Newsworthiness bucket
Research
一家主要制药公司在药物发现领域对AI进行的大量投资。 [lever_c_demoted from significant: ic=1 ai=0.7]
Source corroboration
Single-source cluster
Only one publisher covered this so far. Single-source stories can still rank when the publisher is high-authority, but they lack cross-source corroboration.
Topics
funding, product, other
Editorial topic classification. Feeds into how the story surfaces on /topic/<slug> hub pages and into the per-entity coverage mix.
AI-industry relevance
High
Clearly on-topic for AI-industry coverage.
Story freshness
Breaking (< 6h)
Fresh story with cross-source coverage still developing. Ranking may shift as more sources report.

完整方法见我们的编辑标准。

报道来源 [1]

  1. Mastodon — mastodon.social TIER_1 English(EN) · leonardscheidel ·

    BMS funded the AI that's supposed to tell BMS which drugs will work. $3B for a model that "calculates probability of success." every failed trial just calls it

    BMS funded the AI that's supposed to tell BMS which drugs will work. $3B for a model that "calculates probability of success." every failed trial just calls it an outlier. # Investment # AI

相关实体

相关话题